Tóm tắt
.
Tài liệu tham khảo
Harshvardhan P, Anuradha N. Comparative analysis of fructosamine and HbA1c as a glycemic control marker in Type 2 diabetes patients in a tertiary care hospital study. Asian Journal of Medical Sciences. 2023;14(10):73-78.
Krishnaveni S, Sirivelu B, Sucheta YBD, Veeranna B. Association of fructosamine, glycated albumin and hba1c in prediabetes, diabetic and associated complications. International journal of health sciences. 2022;6(S7):4693-4699.
Vasileva B, Gatev E, Aleksandrov A, Kerezieva S, Ilieva S, Popova D, et al. Serum Fructosamine as a Marker for Glycemic Control in Patients with Diabetic Nephropathy. Proceedings of the Bulgarian Academy of Sciences. 2024;77(3):442–450.
Cefalu WT, Parker TB, Johnson CR. Validity of serum fructosamine as index of short-term glycemic control in diabetic outpatients. Diabetes Care.1988;11(8):662-4.
Goyal J, Das N, Kumar N, Raghav MS, Bhatia PS, Singh KP, et al. Comparative evaluation of fructosamine and HbA1c as a marker of glycemic control in Type 2 diabetes: A hospital based study. Int J Health Sci Res. 2019;9(9):269-274.
Chandran K, Lee SM, Shen L, Tng EL. Fructosamine and HbA1c: A Correlational Study in a Southeast Asian Population. J ASEAN Fed Endocr Soc. 2024;39(1):26-30.
Baker JR, Metcalf PA, Johnson RN, Newman D, Rietz P. Use of protein-based standards in automated colorimetric determinations of fructosamine in serum. Clin Chem. 1985;31(9):1550-4.
Đã xuất bản | 01-01-2025 | |
Toàn văn |
|
|
Ngôn ngữ |
|
|
Số tạp chí | Tập 16 Số 9 (2024) | |
Phân mục | Nghiên cứu | |
DOI | 10.38103/jcmhch.16.9.18 | |
Từ khóa |

công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International . p>
Bản quyền (c) 2024 Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế